MedTech News
.................... by Andrew Celentano

Cancer-promoting proteins may make tumors easier to spot… but also help them evade immune attack
The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.

New swab test could spare some women a painful biopsy for endometrial cancer
A simple vaginal swab may one day help women with abnormal bleeding learn whether they have endometrial cancer without first going through a painful biopsy.

Magnetic bead implants could offer more accurate way to control prosthetic limbs
MIT researchers have shown that they can accurately track muscle movement using tiny magnetic beads implanted in the muscle. These measurements could make it easier for people with certain types of amputations to control their prosthetic limbs.

CereVasc Receives FDA IDE Approval to Evaluate the eShunt® System in Patients with Alzheimer’s Disease
FDA authorization enables clinical investigation of a fundamentally different approach for patients with early symptomatic Alzheimer’s disease

An Experimental Antibody Kept HIV’s Monkey Counterpart in Remission for up to Four Years
A single dose of an antibody targeting immune cells helped some monkeys stay free of detectable virus long after stopping treatment.

StimCardio Closes Oversubscribed $30 Million Series A for Wearable Atrial Fibrillation Therapy
StimCardio, a Los Angeles, CA-based clinical-stage medical device company developing non-invasive wearable therapeutics for atrial fibrillation (AF), has announced the closing of its oversubscribed $30 million Series A financing.

Blood test offers new way to track lung cancer
Northwestern Medicine scientists and collaborators have demonstrated a novel liquid biopsy technique that can measure cancer burden and reveal molecular characteristics of small cell lung cancer (SCLC), according to a new study published in the Journal of Clinical Investigation.

Immune system protein is a cancer killer on its own, new study shows
For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell. Now, new work led by researchers at the University of Michigan Health Rogel Cancer Center found that tumor cells could be killed even when major granzymes were missing.